Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares KNSA
$77.83
-0.41%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-08-04 | View → |
| 4 | Insider transaction | 2026-07-31 | View → |
| 10-Q | 10-Q | 2026-07-28 | View → |
| 8-K | 8-K | 2026-07-28 | View → |
| 4 | Insider transaction | 2026-07-06 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 8-K | 8-K | 2026-05-29 | View → |
| 8-K | 8-K | 2026-05-26 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-04-30 | View → |
| 4 | Insider transaction | 2026-04-29 | View → |
| 10-Q | 10-Q | 2026-04-28 | View → |
| 8-K | 8-K | 2026-04-28 | View → |
| DEF 14A | DEF 14A | 2026-04-16 | View → |
| 4 | Insider transaction | 2026-04-13 | View → |
| 4 | Insider transaction | 2026-04-13 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-03-11 | View → |
| 4 | Insider transaction | 2026-03-04 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $77.83
- Market Cap
- $6.10 billion
- 52-Week Range
- $26.27 – $82.94
- Average Volume
- 689K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.